HAI Pathogens and Antimicrobial Resistance Report, 2018-2021
Adult Data Tables
PAGE 5 of 19
‹View Table of Contents
Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type, Adults, 2018-2021
Acute Care Hospitals (n=2,988 hospitals) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospital ICUs | Hospital Wards1 | Hospital Oncology Units2 | LTACHs3 (n=420 hospitals) |
|||||||||
Pathogen | # Pathogens | % Pathogens | Rank | # Pathogens | % Pathogens | Rank | # Pathogens | % Pathogens | Rank | # Pathogens | % Pathogens | Rank |
Coagulase-negative staphylococci | 7,553 | 17.0 | 1 | 4,181 | 10.9 | 2 | 2,380 | 10.6 | 2 | 886 | 10.7 | 3 |
Enterococcus faecalis4 | 5,539 | 12.5 | 2 | 3,344 | 8.7 | 4 | 970 | 4.3 | 8 | 1,088 | 13.2 | 1 |
Candida albicans4 | 5,363 | 12.1 | 3 | 2,574 | 6.7 | 6 | 260 | 1.2 | 16 | 451 | 5.5 | 7 |
Other Candida spp.4 | 3,813 | 8.6 | 4 | 2,287 | 5.9 | 7 | 631 | 2.8 | 10 | 818 | 9.9 | 5 |
Staphylococcus aureus | 3,288 | 7.4 | 5 | 5,914 | 15.4 | 1 | 1,307 | 5.8 | 6 | 910 | 11.0 | 2 |
Enterococcus faecium4 | 3,200 | 7.2 | 6 | 1,884 | 4.9 | 8 | 1,974 | 8.8 | 4 | 487 | 5.9 | 6 |
Candida glabrata4 | 3,126 | 7.0 | 7 | 1,677 | 4.4 | 9 | 328 | 1.5 | 14 | 343 | 4.2 | 9 |
Select Klebsiella spp. | 2,074 | 4.7 | 8 | 3,519 | 9.1 | 3 | 1,824 | 8.2 | 5 | 874 | 10.6 | 4 |
Escherichia coli | 1,323 | 3.0 | 9 | 2,601 | 6.8 | 5 | 3,923 | 17.5 | 1 | 335 | 4.1 | 10 |
Pseudomonas aeruginosa | 1,316 | 3.0 | 10 | 1,644 | 4.3 | 10 | 1,011 | 4.5 | 7 | 414 | 5.0 | 8 |
Enterobacter spp. | 1,037 | 2.3 | 11 | 1,374 | 3.6 | 11 | 741 | 3.3 | 9 | 277 | 3.4 | 11 |
Serratia spp. | 834 | 1.9 | 12 | 765 | 2.0 | 12 | 149 | 0.7 | 21 | 191 | 2.3 | 13 |
Other Enterococcus spp.4 | 735 | 1.7 | 13 | 496 | 1.3 | 14 | 426 | 1.9 | 11 | 91 | 1.1 | 16 |
Yeast, not specified | 516 | 1.2 | 14 | 283 | 0.7 | 19 | 10 | <0.1 | 79 | 138 | 1.7 | 15 |
Acinetobacter spp. | 448 | 1.0 | 15 | 473 | 1.2 | 16 | 63 | 0.3 | 31 | 158 | 1.9 | 14 |
Other pathogen | 4,321 | 9.7 | 5,483 | 14.2 | 6,371 | 28.5 | 790 | 9.6 | ||||
Total | 44,486 | 100.0 | 38,499 | 100.0 | 22,368 | 100.0 | 8,251 | 100.0 |
Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.
Footnotes:
- Some rankings are not shown: Proteus (#13, 1.4%); Viridans group streptococci (#15, 1.3%).
- Some rankings are not shown: Viridans group streptococci (#3, 10.2%); Bacteroides (#12, 1.6%); Rothia mucilaginosa (#13, 1.6%); Gemella haemolysans (#15, 1.2%).
- Some rankings are not shown: Proteus spp. (#12, 2.4%).
- When analyzed at the genus-level, Candida and Enterococcus spp. resulted in the following rankings:
- Candida spp. – hospital ICUs (#1, 27.7%); hospital wards (#1, 17.0%); hospital oncology units (#7, 5.4%); LTACHs (#2, 19.5%).
- Enterococcus spp. – hospital ICUs (#2, 21.3%); hospital wards (#3, 14.9%); hospital oncology units (#2, 15.1%); LTACHs (#1, 20.2%).
HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs
- HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
- Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
- Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
- Table 3. The Top 15 HAI Pathogens Reported to NHSN
- ›Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
- Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
- Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
- Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
- Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
- Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
- Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
- Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
- Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
- Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
- Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
- Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
- Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
- Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
- Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type